HomeRSLS • NASDAQ
add
ReShape Lifesciences Inc
Previous close
$4.72
Day range
$4.43 - $4.59
Year range
$4.09 - $29.00
Market cap
3.21M USD
Avg Volume
24.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.29M | 6.36% |
Operating expense | 3.20M | -27.12% |
Net income | -1.58M | 55.26% |
Net profit margin | -68.98 | 57.94% |
Earnings per share | — | — |
EBITDA | -1.76M | 42.48% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 743.00K | -48.72% |
Total assets | 5.62M | -28.26% |
Total liabilities | 4.13M | -12.98% |
Total equity | 1.49M | — |
Shares outstanding | 712.68K | — |
Price to book | 2.24 | — |
Return on assets | -73.33% | — |
Return on capital | -178.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.58M | 55.26% |
Cash from operations | -311.00K | 88.81% |
Cash from investing | — | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -310.00K | 90.06% |
Free cash flow | 198.38K | 112.54% |
About
Founded
2002
Headquarters
Website
Employees
29
